Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RxHub formulary transfer protocol (correction)

Executive Summary

RxHub's formulary and benefit file transfer protocol is based on proprietary technology. The protocol is the basis for a National Council for Prescription Drug Programs standard currently in development which will be made public as a standardized formulary and benefit transfer protocol. "The Pink Sheet" incorrectly reported that RxHub's protocol is based on the Veterans Administrations' National Drug File-Reference Terminology (1"The Pink Sheet" Sept. 6, 2004, p. 16). RxHub uses National Drug Classification codes to identify particular products within the formulary. The National Committee on Vital & Health Statistics recommended that FDA incorporate the VA's classification into structured product labels, which map NDC codes to RxNorm, the electronic prescribing standard...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel